Cite
Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer.
MLA
Duan, Ningjun, et al. “Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer.” Advanced Science, vol. 11, no. 18, May 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1002/advs.202309424.
APA
Duan, N., Hua, Y., Yan, X., He, Y., Zeng, T., Gong, J., Fu, Z., Li, W., & Yin, Y. (2024). Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer. Advanced Science, 11(18), 1–15. https://doi.org/10.1002/advs.202309424
Chicago
Duan, Ningjun, Yijia Hua, Xueqi Yan, Yaozhou He, Tianyu Zeng, Jue Gong, Ziyi Fu, Wei Li, and Yongmei Yin. 2024. “Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer.” Advanced Science 11 (18): 1–15. doi:10.1002/advs.202309424.